Home › Conditions › NSTEMI / Unstable Angina
Cardiology
NSTEMI / Unstable Angina
NSTEMI: acute myocardial injury with ischaemia, without persistent ST elevation. Use GRACE + clinical features. Shock/refractory ischaemia: immediate angiography; stable high-risk NSTE-ACS: consider within 24 h (ESC).
NSTEACS Risk Stratification
The pathway
ECG & troponin
- ECG at 0h — look for ST depression, T-wave changes, or new LBBB
- hs-Troponin at 0h and 1–3h, using the validated assay pathway
- Rise/fall above the 99th percentile + evidence of ischaemia supports NSTEMI; troponin rise alone means injury, not necessarily infarction.
GRACE score
Calculate GRACE 2.0 score (age, HR, SBP, Cr, Killip class, troponin, ST deviation, cardiac arrest). >140 = high risk, <109 = low risk. Drives angiography timing.
Dual antiplatelet therapy
- Aspirin 300mg loading dose
- If anatomy is unknown and angiography planned within 24h, do not routinely pre-load a P2Y12 inhibitor
- If angiography is delayed, discuss ticagrelor 180mg loading with cardiology after bleeding-risk assessment
Anticoagulation
- Fondaparinux 2.5mg SC OD unless high bleeding risk or immediate angiography (NICE); avoid CrCl <20mL/min
- Immediate angiography/PCI: coordinate UFH with the cath lab; additional UFH is needed at PCI even after fondaparinux
- If enoxaparin is selected: 1mg/kg SC BD; OD if CrCl15–30mL/min, seek an alternative if <15
- Continue to invasive treatment; review the plan if managed medically
Angiography timing
- Very high-risk (shock, refractory ischaemia): call cardiology for immediate angiography
- High-risk (e.g. GRACE >140, confirmed NSTEMI, dynamic ST/T changes): consider angiography within 24 h (ESC)
- Intermediate or higher risk (predicted 6-month mortality >3%): consider within 72 h of first admission, if no contraindications (NICE)
- Low risk: non-invasive testing; recurrent/demonstrated ischaemia → cardiology/angiography
Secondary prevention
- High-intensity statin (atorvastatin 80mg)
- Beta-blocker
- ACEi
- Dual antiplatelet 12 months
- Cardiac rehab
- Driving (Group 1): 1 week after successful PCI only if EF≥40%, no urgent further revascularisation and no other disqualifier; otherwise ≥4 weeks. Group 2: stop and notify DVLA; relicensing assessment after ≥6 weeks
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Aspirin | 300mg stat, then 75mg OD | PO | Loading dose immediately. |
| Ticagrelor | 180mg stat, then 90mg BD | PO | If selected: 180mg load, then 90mg BD. No routine pretreatment if anatomy unknown and angiography planned within24h; assess bleeding risk. |
| Fondaparinux | 2.5mg OD | SC | Preferred initial option unless high bleeding risk or immediate angiography (NICE). Avoid CrCl <20mL/min. Additional UFH at PCI. |
| Atorvastatin | 80mg OD | PO | High-intensity statin. Start immediately. |
| GTN spray | 400mcg | SL | Avoid if SBP <90 or on PDE5i. IV GTN for refractory ischaemia. |
When to escalate
- Cardiogenic shock — call cardiology/ITU for immediate angiography; vasopressors if needed
- Refractory ischaemia on medical therapy — immediate angiography
- Haemodynamic instability — HDU/ITU
- Post-MI pericarditis (early; Dressler's weeks later) — discuss with cardiology: anti-inflammatory-dose aspirin + colchicine preferred
Reference: ESC Guidelines for the management of acute coronary syndromes (2023) / NICE NG185
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.